An artificial intelligence (AI) model that analyzes brain scans alongside clinical and demographic data showed high accuracy in predicting which people with multiple sclerosis (MS) were likely to experience cognitive decline over time, according to a new study. Using tools that show which parts of the data most influenced…
Discussion
Even with my husband, Rhead, living in an assisted-living facility, there are so many hard days when I become somewhat of a punching bag. One visit, he is light and funny, the version of him I fell in love with, and the next, he can turn sharp and far away,…
Discussion
The number of people living with multiple sclerosis (MS) has risen steadily over the past two decades, but the increase appears to be driven largely by longer survival after diagnosis rather than by more people developing the disease. That’s according to findings of a large study that analyzed nationwide…
Discussion
Imviva Biotech is cleared to launch a basket Phase 1b trial testing its investigational off-the-shelf CAR T-cell therapy CTA313 in progressive multiple sclerosis (MS) and other B-cell-mediated autoimmune diseases. The announcement follows the clearance of the company’s investigational new drug (IND) application by the U.S. Food and Drug…
Discussion
Among people with clinically isolated syndrome (CIS) — an initial episode of symptoms suggestive of multiple sclerosis (MS) — lower levels of certain fatty molecules in the blood are associated with higher rates of future disease relapses, a new study found. Adding these metabolic features to established demographic…
Get regular updates to your inbox.
